CENP-F gene amplification and overexpression in head and neck squamous cell carcinomas

被引:7
作者
de la Guardia, C
Casiano, CA
Trinidad-Pinedo, J
Báez, A
机构
[1] Univ Puerto Rico, Sch Med, Dept Pharmacol, San Juan, PR 00936 USA
[2] Loma Linda Univ, Sch Med, Dept Microbiol & Mol Genet, Loma Linda, CA USA
[3] Loma Linda Univ, Sch Med, Ctr Mol Biol & Gene Therapy, Loma Linda, CA USA
[4] Univ Puerto Rico, Sch Med, Dept Otolaryngol, San Juan, PR 00936 USA
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2001年 / 23卷 / 02期
关键词
CENP-F; c-MYC; head and neck cancer; gene amplification;
D O I
暂无
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Antibodies against cancer-related genes have been detected in human cancers including head and neck cancers. High titers of c-Myc autoantibodies have been linked to gene amplification and tumor progression. Centromere protein-F (CENP-F) autoantibodies have been detected in patients with various cancers, suggesting similar gene alteration. Methods. CENP-F and c-MYC amplification was assessed in 72 head and neck squamous cell carcinoma (HNSCC) patients. Tumor and matched mucosa from 22 patients were analyzed for CENP-F mRNA levels by RT-PCR. Results. The larynx was the site most altered by amplification of either gene. CENP-F and c-MYC were amplified in 11% and 17% of the tumors, respectively. Coamplification was found in 7% of the tumors, most of which showed regional node involvement. CENP-F mRNA was overexpressed in 36% of tumors, and 23% of paired mucosa. Conclusion. Our results provide the first evidence that CENP-F gene is amplified and overexpressed in HNSCC. No correlation was noted between CENP-F amplification and clinicopathologic parameters. However, CENP-F overexpression correlated with nodal metastasis. (C) 2001 John Wiley & Sons, Inc.
引用
收藏
页码:104 / 112
页数:9
相关论文
共 58 条
[1]  
Augenlicht LH, 1997, CANCER RES, V57, P1769
[2]   Expression of proliferation-associated nuclear autoantigens, p330(d)/CENP-F and PCNA, in differentiation and in drug-induced growth inhibition using two-parameter flow cytometry [J].
Baez, A ;
Torres, K ;
Tan, EM ;
Pommier, Y ;
Casiano, CA .
CELL PROLIFERATION, 1996, 29 (04) :183-196
[3]   CIRCULATING ANTIBODIES AGAINST C-MYC ONCOGENE PRODUCT IN SERA OF COLORECTAL-CANCER PATIENTS [J].
BENMAHREZ, K ;
SOROKINE, I ;
THIERRY, D ;
KAWASUMI, T ;
ISHII, S ;
SALMON, R ;
KOHIYAMA, M .
INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (01) :35-38
[4]  
Bièche I, 1999, CANCER RES, V59, P2759
[5]  
Bockmuhl U, 1998, HEAD NECK-J SCI SPEC, V20, P145, DOI 10.1002/(SICI)1097-0347(199803)20:2<145::AID-HED8>3.0.CO
[6]  
2-2
[7]  
Boyum A, 1968, SCAND J CLIN LAB S97, V21, P7
[8]   Role of amplified genes in the production of autoantibodies [J].
Brass, N ;
Rácz, A ;
Bauer, C ;
Heckel, D ;
Sybrecht, G ;
Meese, E .
BLOOD, 1999, 93 (07) :2158-2166
[9]   AUTOIMMUNITY TO THE CELL CYCLE-DEPENDENT CENTROMERE PROTEIN P330(D)/CENP-F IN DISORDERS ASSOCIATED WITH CELL-PROLIFERATION [J].
CASIANO, CA ;
HUMBEL, RL ;
PEEBLES, C ;
COVINI, G ;
TAN, EM .
JOURNAL OF AUTOIMMUNITY, 1995, 8 (04) :575-586
[10]  
CASIANO CA, 1993, J CELL SCI, V106, P1045